Leonard L. Mazur

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cranford, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alexander M. Donaldson, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Leonard L. Mazur

Form 4 holding Chief Executive Officer, Director

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
3,700,000
Estimated value
$7,733,000
Report date
19 Sep 2025
Price
$2.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,700,000
Form 4 holding Chief Executive Officer, Director

Citius Pharmaceuticals, Inc.

Security class
Warrant to Purchase Common Stock
Shares / value
89,388
Estimated value
Report date
08 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,165,048
Form 4 holding Director

Tharimmune, Inc.

Security class
Options (right to buy)
Shares / value
27,353
Estimated value
Report date
09 Aug 2024
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Citius Pharmaceuticals, Inc.

Security class
Stock Option (Right to Purchase Common Stock)
Shares / value
1,600
Estimated value
Report date
08 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000

Insider Reports Filed by Leonard L. Mazur

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .